BioGaia´ s Investment In Far East Gives Results

The Far East is BioGaia´s most important and prioritised market. For a year and a half BioGaia have had a representative in place in Hong Kong and have also engaged an agent for the Chinese market.

In the Far East, Japan represents BioGaia´s single largest market. For 10 years Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan. The contract expired at the end of 2005. A new long contract with improved terms has now been signed with Chichiyasu.

Further, BioGaia has signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. Age D'Or is a distributor for a number of larger pharmaceutical companies and sells mainly through hospitals and doctors.

"It is very pleasing to see that our focus on the Far East is giving results and that our long time customer Chichiyasu is investing strongly in dairy products with Reuteri", says Peter Rothschild, Managing Director of BioGaia.

For additional information contact:
Peter Rothschild, Managing Director, BioGaia AB, telephone 46 (0)8-555 293 00
Jan Annwall, Deputy Managing Director, BioGaia AB, telephone: +46 (0)8 - 555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health effects. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic or health-enhancing effects. The Parent Company BioGaia AB's class B share is quoted on the O list of the Stockholm Stock Exchange.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.